Literature DB >> 22806040

Generating DNA sequences encoding tandem peptide repeats suitable for expression and immunological application.

Hongwei Hou1, Zhiqian Zhang, Wei Zhao, Jinyan Hou.   

Abstract

Tandem repeats of single short peptide sequences are useful for many purposes. Here we describe a method called ligation-PCR to construct DNA sequences encoding numerous tandem peptide repeats that can stably produce such repeats in both prokaryotic and eukaryotic cells. The method employs double-strand target monomers consisting of a short peptide coding sequences. These sequences contain 3-bp cohesive overhangs to ensure correct repeat orientation and reading frame during ligation. The ligation products are PCR amplified and directly cloned into a new TA-cloning vector, pZeroT. Constructs containing tandem 10-amino-acid myc-tag peptide coding sequence repeats that ranged from approximately 0.45-1.2 kb, representing 15-40 copies of the corresponding peptide, were successfully obtained by this method. When one of the constructs was subcloned into prokaryotic vector pET-28 c (+) and eukaryotic vector rGHpcDNA3.0, and introduced into E. Coli and COS-7 cells, respectively, proteins containing tandem myc-tag peptide repeats were expressed with expected molecular weights. Purified proteins from E. Coli could successfully stimulate a peptide specific immune response. This method provides a means to manipulate peptides at the nucleic acid level, and can serve as the basis for biological peptide synthesis, epitope-specific antibody production, and epitope-based DNA vaccine construction.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22806040     DOI: 10.1007/s11274-012-1023-4

Source DB:  PubMed          Journal:  World J Microbiol Biotechnol        ISSN: 0959-3993            Impact factor:   3.312


  17 in total

1.  XcmI site-containing vector for direct cloning and in vitro transcription of PCR product.

Authors:  N Arashi-Heese; M Miwa; H Shibata
Journal:  Mol Biotechnol       Date:  1999-10       Impact factor: 2.695

2.  Therapeutic LMP1 polyepitope vaccine for EBV-associated Hodgkin disease and nasopharyngeal carcinoma.

Authors:  Jaikumar Duraiswamy; Martina Sherritt; Scott Thomson; Judy Tellam; Leanne Cooper; Geoff Connolly; Mandvi Bharadwaj; Rajiv Khanna
Journal:  Blood       Date:  2002-12-05       Impact factor: 22.113

Review 3.  Dissecting the role of peptides in the immune response: theory, practice and the application to vaccine design.

Authors:  Anthony W Purcell; Weiguang Zeng; Nicole A Mifsud; Lauren K Ely; Whitney A Macdonald; David C Jackson
Journal:  J Pept Sci       Date:  2003-05       Impact factor: 1.905

Review 4.  Technological advances in antigen delivery and synthetic peptide vaccine developmental strategies.

Authors:  C Olive; I Toth; D Jackson
Journal:  Mini Rev Med Chem       Date:  2001-11       Impact factor: 3.862

Review 5.  Design of synthetic peptidic constructs for the vaccine development against viral infections.

Authors:  Isabel Haro; María José Gómara
Journal:  Curr Protein Pept Sci       Date:  2004-12       Impact factor: 3.272

6.  pUCPCR1. A vector for direct cloning of PCR products in a double Xcm1 restriction site offering compatible single 3'-overhanging T residues.

Authors:  E de Vries
Journal:  Mol Biotechnol       Date:  1998-12       Impact factor: 2.695

7.  XcmI-containing vector for direct cloning of PCR products.

Authors:  A Y Borovkov; M I Rivkin
Journal:  Biotechniques       Date:  1997-05       Impact factor: 1.993

8.  Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system.

Authors:  J P Tam
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

9.  Multiple joined genes prevent product degradation in Escherichia coli.

Authors:  S H Shen
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

10.  New vectors for direct cloning of PCR products.

Authors:  J Cha; W Bishai; S Chandrasegaran
Journal:  Gene       Date:  1993-12-22       Impact factor: 3.688

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.